Previous studies have demonstrated that Arhgap25 regulates the proliferation of human pancreatic cancer cells via HIF-1α [33], leading us to hypothesize that RhoA modulates glycolytic processes through Arhgap25/HIF-1α pathway. The gene discussed is HIF1A; the disease is pancreatic neoplasm.